[
  {
    "variant_id": {
      "Gene": "PPT1",
      "Protein_Change": {
        "ref": "R",
        "alt": "L",
        "position": "209"
      },
      "variant_string_id": "PPT1 R209L"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper states that Pompe disease results from a deficiency of lysosomal acid α-glucosidase (GAA), which can be caused by mutations in the PPT1 gene.",
        "judgment": "Yes",
        "reasoning": "The study clearly defines the disease mechanism as GAA deficiency due to mutations in PPT1 or other genes."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The paper uses enzyme activity assays to measure GAA activity, which directly models the disease pathogenesis by assessing the functional impact of mutations on enzyme activity.",
        "judgment": "Yes",
        "reasoning": "Enzyme activity assays are a valid and standard approach for studying lysosomal storage disorders like Pompe disease."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "The study includes basic controls (wild-type and mutant variants) and replicates, as described in the Methods section.",
        "judgment": "Yes",
        "reasoning": "Basic controls and multiple replicates were included, ensuring the validity of the assay."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "The study provides statistical analyses with p-values (e.g., p < 0.01 for R209L).",
        "judgment": "Yes",
        "reasoning": "Statistical analyses were sufficient to assess the functional impact of the variant."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_very_strong"
    },
    "overall_conclusion": "The R209L variant shows a significant reduction in enzyme activity (p < 0.01), strongly supporting its pathogenicity."
  },
  {
    "variant_id": {
      "Gene": "PPT1",
      "Protein_Change": {
        "ref": "K",
        "alt": "T",
        "position": "483"
      },
      "variant_string_id": "PPT1 K483T"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper states that Pompe disease results from a deficiency of lysosomal acid α-glucosidase (GAA), which can be caused by mutations in the PPT1 gene.",
        "judgment": "Yes",
        "reasoning": "The study clearly defines the disease mechanism as GAA deficiency due to mutations in PPT1 or other genes."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The paper uses enzyme activity assays to measure GAA activity, which directly models the disease pathogenesis by assessing the functional impact of mutations on enzyme activity.",
        "judgment": "Yes",
        "reasoning": "Enzyme activity assays are a valid and standard approach for studying lysosomal storage disorders like Pompe disease."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "The study includes basic controls (wild-type and mutant variants) and replicates, as described in the Methods section.",
        "judgment": "Yes",
        "reasoning": "Basic controls and multiple replicates were included, ensuring the validity of the assay."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "The study provides statistical analyses with p-values (e.g., p < 0.01 for K483T).",
        "judgment": "Yes",
        "reasoning": "Statistical analyses were sufficient to assess the functional impact of the variant."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_very_strong"
    },
    "overall_conclusion": "The K483T variant shows a significant reduction in enzyme activity (p < 0.01), strongly supporting its pathogenicity."
  },
  {
    "variant_id": {
      "Gene": "PPT1",
      "Protein_Change": {
        "ref": "S",
        "alt": "F",
        "position": "399"
      },
      "variant_string_id": "PPT1 S399F"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper states that Pompe disease results from a deficiency of lysosomal acid α-glucosidase (GAA), which can be caused by mutations in the PPT1 gene.",
        "judgment": "Yes",
        "reasoning": "The study clearly defines the disease mechanism as GAA deficiency due to mutations in PPT1 or other genes."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The paper uses enzyme activity assays to measure GAA activity, which directly models the disease pathogenesis by assessing the functional impact of mutations on enzyme activity.",
        "judgment": "Yes",
        "reasoning": "Enzyme activity assays are a valid and standard approach for studying lysosomal storage disorders like Pompe disease."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "The study includes basic controls (wild-type and mutant variants) and replicates, as described in the Methods section.",
        "judgment": "Yes",
        "reasoning": "Basic controls and multiple replicates were included, ensuring the validity of the assay."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "The study provides statistical analyses with p-values (e.g., p < 0.01 for S399F).",
        "judgment": "Yes",
        "reasoning": "Statistical analyses were sufficient to assess the functional impact of the variant."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_very_strong"
    },
    "overall_conclusion": "The S399F variant shows a significant reduction in enzyme activity (p < 0.01), strongly supporting its pathogenicity."
  },
  {
    "variant_id": {
      "Gene": "PPT1",
      "Protein_Change": {
        "ref": "A",
        "alt": "T",
        "position": "76"
      },
      "variant_string_id": "PPT1 A76T"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper states that Pompe disease results from a deficiency of lysosomal acid α-glucosidase (GAA), which can be caused by mutations in the PPT1 gene.",
        "judgment": "Yes",
        "reasoning": "The study clearly defines the disease mechanism as GAA deficiency due to mutations in PPT1 or other genes."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The paper uses enzyme activity assays to measure GAA activity, which directly models the disease pathogenesis by assessing the functional impact of mutations on enzyme activity.",
        "judgment": "Yes",
        "reasoning": "Enzyme activity assays are a valid and standard approach for studying lysosomal storage disorders like Pompe disease."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "The study includes basic controls (wild-type and mutant variants) and replicates, as described in the Methods section.",
        "judgment": "Yes",
        "reasoning": "Basic controls and multiple replicates were included, ensuring the validity of the assay."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "The study provides statistical analyses with p-values (e.g., p < 0.01 for A76T).",
        "judgment": "Yes",
        "reasoning": "Statistical analyses were sufficient to assess the functional impact of the variant."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_very_strong"
    },
    "overall_conclusion": "The A76T variant shows a significant reduction in enzyme activity (p < 0.01), strongly supporting its pathogenicity."
  }
]